In The News Posted August 25, 2021 Share Posted August 25, 2021 EWING, N.J., Aug. 25, 2021 /PRNewswire/ -- NovaRock Biotherapeutics Limited, a clinical-stage biopharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs, today announced that they have entered into an exclusive license agreement and...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.